Monoclonal iga antibody against respiratory syncytial virus

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/18 (2006.01) A61K 39/42 (2006.01) C07K 14/135 (2006.01) C07K 16/10 (2006.01) G01N 33/569 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2167835

The present invention relates to antibodies directed against Respiratory Syncytial Virus (RSV), and hybridoma lines which produce them (e.g., HNK20). The antibodies can be used for the prevention or treatment of RSV infection and disease, as well as employed in methods for diagnosing RSV infection.

Cette invention concerne des anticorps dirigés contre le virus respiratoire syncytial (RSV) et des lignées cellulaires d'hybridomes qui les produisent (HNK20 par exemple). Ces anticorps peuvent être utilisés pour prévenir ou traiter l'infection à RSV et la maladie associée, et dans des procédés de diagnostic de l'infection à RSV.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal iga antibody against respiratory syncytial virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal iga antibody against respiratory syncytial virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal iga antibody against respiratory syncytial virus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1915960

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.